Oxford Uni Trialing Drug That Could Aid Recovery From COVID-19

Oxford University has announced that it is trialing a drug that seeks to aid respiratory recovery from COVID-19.

• A proportion of those that suffer from moderate or severe symptoms of COVID-19 continue to experience these symptoms even when they no longer have the virus, an effect known as 'long COVID'.
• The impact of 'long COVID' on national healthcare sectors, and therefore gov't budgets or household finances (depending on the country's healthcare sector setup) could be substantial, and therefore an effective treatment for managing the LT impacts of the disease could have significant economic benefits for gov't and household finances in the years to come.